PRTA
PRTA
NASDAQ · Biotechnology

Prothena Corp Plc

$10.73
+0.21 (+2.00%)
As of May 10, 10:21 PM ET ·
Financial Highlights (FY 2026)
Revenue
10.10M
Net Income
-254,550,026
Gross Margin
Profit Margin
-2,520.6%
Rev Growth
-43.6%
D/E Ratio
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 66.9% 66.9%
Operating Margin -2,216.4% -1,994.8% -17.7% -18.1%
Profit Margin -2,520.6% -2,394.5% -16.3% -12.8%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 10.10M 17.90M 162.70M 132.11M
Gross Profit 108.91M 88.43M
Operating Income -223,831,537 -356,988,097 -28,741,203 -23,889,033
Net Income -254,550,026 -405,980,902 -26,550,677 -16,869,914
Gross Margin 66.9% 66.9%
Operating Margin -2,216.4% -1,994.8% -17.7% -18.1%
Profit Margin -2,520.6% -2,394.5% -16.3% -12.8%
Rev Growth -43.6% -43.6% +13.5% +18.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 103.68M 102.66M
Total Equity 280.84M 243.54M
D/E Ratio 0.37 0.42
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -223,243,505 -375,830,816 -39,466,979 -33,822,388
Free Cash Flow -19,760,246 -19,201,664